Özgür AKGÜL, Hamdi PUŞÜROĞLU

Sistatin C: Kardiyovasküler Hastalıklar İçin Yeni Prediktif Bir Markör

Cystatin C: A Novel Predictive Marker for Cardiovascular Disease

1. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator ofglomerular filtration rate? Clin Chem 2002;48:699-707.
2. Parikh NI, Hwang SJ, Yang Q, Larson MG, Guo CY, Robins SJ, et al. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008;102:11948.
3. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL,Nevman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60.
4. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease:the heart and soul study.J Am Soc Nephrol.2003;14(12):3233-8.
5. Taglieri N, Fernandez-Berges DJ, Koenig W, Consueqra - SanchezL, Fernandez JM, Robles NR, et al. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis 2010;209:300-5.
6. Akgul O, Uyarel H, Ergelen M, Pusuroglu H, Gul M,Turen S, et al. Predictive value of elevated elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Journal of Critical Care. 2013;28(5):882.e13-20.